Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DVAX | DYNAVAX TECHNOLOGIES CORP | Director | $200K | May 23, 2024 | ||
HSTO | Histogen Inc. | Director | Jun 20, 2023 | |||
ONCT | Oncternal Therapeutics, Inc. | Director | Jun 20, 2024 | |||
ZYNE | Zynerba Pharmaceuticals, Inc. | Director | Oct 10, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|